logo

Checkmate Pharmaceuticals, Inc. (CMPI)



Trade CMPI now with
  Date
  Headline
4/19/2022 7:06:32 AM Regeneron To Acquire Checkmate Pharma For $10.50/Shr
5/4/2021 7:36:41 AM Checkmate Pharma Doses Patient In Potential Registration Trial Of Vidutolimod In Anti-PD-1 Refractory Advanced Melanoma
4/19/2021 6:15:38 AM Checkmate Announces Initiation Of Dosing In Phase 2 Proof-of-concept Trial In Patients With HNSCC